In this episode, Tod and David discuss what to expect from Congress going into 2023, including the debt ceiling, inflation, appropriations funding, and entitlement programs.

Tod Ibrahim and David White interview Zachary Kribs, ASN Manager of Congressional Affairs, on what to expect during the lame-duck session of Congress, agenda items for the newly elected Congress, and funding for kidney health projects in the future.

In this episode, Catherine Godson, PhD, leads a discussion with Orlando M. Gutierrez, MD, and Josh Waitzman, MD, PhD, on day 3 of Kidney Week.

In this episode, ASN Kidney Week Committee Co-Chair Kirk Campbell, MD, FASN, leads a discussion with Precious McCowan, MS, and Amy Mottl, MD, MPH, FASN, about day 2 of Kidney Week.

In this episode, ASN President Susan E. Quaggin, MD, FASN, leads a discussion with S. Ananth Karumanchi, MD, and Rachel Lennon, MBBS, PhD, about day 1 of Kidney Week and returning to an in-person program.

Tod and David interview Melissa West, ASN's Senior Director for Strategic Relations and Patient Engagement, about the ASN Taskforce on the Future of Nephrology.

Tod and David discuss the aftermath of the Supreme Court's decision in Marietta Memorial Hospital Employee Health Benefit Plan v. DaVita, Inc. and ASN's response to the Centers for Medicare and Medicaid Services' proposed rules and the

In this episode, Tod and David discuss the proposed rules for the CMS ESRD Prospective Payment System Quality Incentive Program, ASN's responses to the proposed regulation, other issues ASN is working to address, and much more.

In this episode, Tod Ibrahim and David White discuss the ESRD Benefits Program in 2023, the Inflation Reduction Act of 2022, and the Medicare Secondary Payer Act.

In this episode, Tod Ibrahim interviews Drs. Deidra Crews and Keisha Gibson on the ramifications of removing race from the eGFR equation and the next steps in addressing health disparities.